Loading...
Laboratory Corporation of America Holdings
0JSY.L•LSE
Healthcare
Medical - Equipment & Services
£265.00
£3.95(1.52%)
Laboratory Corporation of America Holdings (0JSY.L) Financial Performance & Income Statement Overview
Review Laboratory Corporation of America Holdings (0JSY.L) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.97%
↑ 6.97%
Operating Income Growth
49.77%
↑ 49.77%
Net Income Growth
78.47%
↑ 78.47%
Operating Cash Flow Growth
19.44%
↑ 19.44%
Operating Margin
8.83%
↑ 8.83%
Gross Margin
28.14%
↑ 28.14%
Net Profit Margin
5.66%
↑ 5.66%
ROE
9.25%
↑ 9.25%
ROIC
7.76%
↑ 7.76%
Laboratory Corporation of America Holdings (0JSY.L) Income Statement & Financial Overview
Review Laboratory Corporation of America Holdings 0JSY.L income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|
Revenue | $3.35B | $3.33B | $3.28B |
Cost of Revenue | $2.40B | $2.43B | $2.38B |
Gross Profit | $948.00M | $896.30M | $904.40M |
Gross Profit Ratio | $0.28 | $0.27 | $0.28 |
R&D Expenses | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $546.00M | $595.20M | $568.60M |
Operating Expenses | $546.00M | $679.80M | $650.30M |
Total Costs & Expenses | $2.94B | $3.11B | $3.03B |
Interest Income | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $63.40M | $50.40M |
Depreciation & Amortization | $166.80M | $170.60M | $161.50M |
EBITDA | $498.00M | $417.80M | $422.50M |
EBITDA Ratio | $0.15 | $0.13 | $0.13 |
Operating Income | $326.00M | $216.50M | $254.10M |
Operating Income Ratio | $0.10 | $0.07 | $0.08 |
Other Income/Expenses (Net) | -$50.80M | -$32.70M | -$43.50M |
Income Before Tax | $275.20M | $183.80M | $210.60M |
Income Before Tax Ratio | $0.08 | $0.06 | $0.06 |
Income Tax Expense | $62.20M | $40.20M | $41.00M |
Net Income | $212.80M | $143.40M | $169.30M |
Net Income Ratio | $0.06 | $0.04 | $0.05 |
EPS | $2.54 | $1.72 | $2.02 |
Diluted EPS | $2.52 | $1.70 | $2.01 |
Weighted Avg Shares Outstanding | $83.60M | $83.60M | $84.00M |
Weighted Avg Shares Outstanding (Diluted) | $84.30M | $84.20M | $84.40M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan